iHateHospitals.com

(Mesothelioma News) BOTHELL, WA and VANCOUVER — OncoGenex Pharmaceuticals announced today that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer. OGX-011 is currently completing five Phase 2 clinical studies in prostate, lung and breast cancer, and [...]

DRUGS & RX: See Web site for additional information on this current drug shortage

View the source of this article…

Drug Shortages: Current Drug Shortages; Zanosar (Streptozocin) Injection was another wonderful and informative drug and pharmaceutical article from your drug and pharmacy information clearance-house iHateHospitals.com!

Hospital Tags: Vioxx Lawsuit, Medical News, information, rx, us, Drugs & RX, pharmaceutical, [...]

DRUGS & RX: See Web site for additional information on this current drug shortage

View the source of this article…

Drug Shortages: Current Drug Shortages; Methadone Hydrochloride Injection was another wonderful and informative drug and pharmaceutical article from your drug and pharmacy information clearance-house iHateHospitals.com!

Hospital Tags: rx, pharmacy, information, Drugs & RX, hospitals, drugs, hospital, us, Medical [...]

DRUGS & RX: The U.S. Food and Drug Administration announced it has cleared for marketing a non-invasive test that uses molecular expression techniques to assist doctors in managing heart transplant patients post-surgery for potential organ rejection.

View the source of this article…

FDA Clears Test to Help Doctors Manage Heart Transplant Patients was another wonderful and informative [...]

DRUGS & RX: The U.S. Food and Drug Administration today approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that can lead to serious bleeding.

View the source of this article…

FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet Counts [...]

DRUGS & RX: The U.S. Food and Drug Administration (FDA) is warning consumers against eating certain frozen cooked mussel products made by Bantry Bay Seafoods, imported from Ireland, because they may be contaminated with azaspiracid toxins, a group of naturally occurring marine toxins known to cause nausea, vomiting, diarrhea, and stomach cramps.

View the source of [...]

DRUGS & RX: The U.S. Food and Drug Administration has approved Xenazine (tetrabenazine) for the treatment of chorea in people with Huntington’s disease. Chorea is the jerky, involuntary movement that occurs in people with this disease.

View the source of this article…

FDA Approves First Drug for Treatment of Chorea in Huntington’s Disease was another wonderful and [...]

DRUGS & RX: THE WOODLANDS, Texas–(BUSINESS WIRE)–Aug 21, 2008 - Repros Therapeutics Inc. (NasdaqGM:RPRX) today released the evaluation of the microscopic assessment of tissues from a six-month mouse study conducted to satisfy a portion of the FDA mandated…

View the source of this article…

Repros Therapeutics Inc. Announces No Tumors in First Completed Proellex Animal Carcinogenicity Study [...]

DRUGS & RX: TITUSVILLE, N.J., August 26, 2008 /PRNewswire/ — Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional data before it will approve the company’s…

View the source of this article…

FDA Issues Complete Response Letter for Paliperidone Palmitate for the Treatment of [...]

DRUGS & RX: WOODCLIFF LAKE, N.J., August 23, 2008 /PRNewswire/ — Eisai Corporation of North America and its partner Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral formulation of Aloxi…

View the source of this article…

FDA Approves Aloxi (palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced [...]

DRUGS & RX: - Clinical data showing unprecedented 89% reduction in risk of GIST relapse with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic filings
EAST HANOVER, N.J., August 27, 2008 /PRNewswire/ — Novartis announced today that Gleevec(R)…

View the source of this article…

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence [...]

DRUGS & RX: SAN DIEGO and INDIANAPOLIS, August 26, 2008 /PRNewswire-FirstCall/ — Amylin Pharmaceuticals, Inc. and Eli Lilly and Company in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug…

View the source of this article…

Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for Byetta [...]